Liting Chen
Shenyang Medical College(CN)University of Southern California(US)Nanchang University(CN)National Yang Ming Chiao Tung University(TW)Changsha Medical University(CN)Shenzhen University(CN)Chinese Academy of Sciences(CN)Chinese Academy of Medical Sciences & Peking Union Medical College(CN)Huazhong Agricultural University(CN)Peking Union Medical College Hospital(CN)Henan University of Technology(CN)Shanghai Children's Medical Center(CN)First Affiliated Hospital of Jiangxi Medical College(CN)People 's Hospital of Jilin Province(CN)Institute of Plant Protection(CN)Institute of Geology and Geophysics(AZ)Institute of Applied Ecology(CN)Guangxi Academy of Fishery Sciences(CN)Princess Máxima Center(NL)First Hospital of China Medical University(CN)National Center for Nanoscience and Technology(CN)Nanning Normal University(CN)Ministry of Agriculture and Rural Affairs(CN)Shenzhen Technology University(CN)Xijing Hospital(CN)Tongji Hospital(CN)Ministry of Education(KN)First Affiliated Hospital of Jinan University(CN)First Affiliated Hospital of Nanchang University(CN)University of Chinese Academy of Sciences(CN)Imaging Center(US)Henan Agricultural University(CN)Huazhong University of Science and Technology(CN)Fujian Agriculture and Forestry University(CN)Fooyin University(TW)China Medical University(CN)Air Force Medical University(CN)
Publications by Year
Research Areas
CAR-T cell therapy research, Virus-based gene therapy research, Lymphoma Diagnosis and Treatment, Viral Infectious Diseases and Gene Expression in Insects, COVID-19 Clinical Research Studies
Most-Cited Works
- → Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): A multicenter, single-blind, randomized controlled trial(2020)475 cited
- → Involvement of Arabidopsis histone deacetylase HDA6 in ABA and salt stress response(2010)342 cited
- → Elevated serum levels of S100A8/A9 and HMGB1 at hospital admission are correlated with inferior clinical outcomes in COVID-19 patients(2020)272 cited
- → Efficacy and safety of CAR19/22 T-cell cocktail therapy in patients with refractory/relapsed B-cell malignancies(2019)257 cited
- → Role of histone deacetylases HDA6 and HDA19 in ABA and abiotic stress response(2010)208 cited
- → A phase 1 study of a novel fully human BCMA-targeting CAR (CT103A) in patients with relapsed/refractory multiple myeloma(2021)206 cited